Abstract
Cerebral ischemic injury evokes a complex cascade of pathophysiological events at the blood–vascular–parenchymal interface. These evolve over time and space and result in progressive neurological damage. Emerging evidence suggests that blood–brain barrier (BBB) recovery and reestablishment of BBB impermeability are incomplete and that these could influence stroke injury recovery, increase the risk of new stroke occurrence, and be a solid substrate for developing vascular dementia. Recent work from the author’s laboratory has established the existence of incomplete BBB recovery in chronic stroke conditions that was induced by structural alterations to brain endothelial junctional complexes and persistent BBB leakage. The experimental methodology presented here is focused on modelling chronic stroke injury using an in vivo thromboembolic mouse stroke model and how to evaluate the kinetics and magnitude of BBB hyperpermeability in chronic stroke conditions using a combination of magnetic resonance imaging, tracer studies, and immunohistochemistry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391–397. https://doi.org/10.1016/s0166-2236(99)01401-0
Delavaran H, Jonsson AC, Lovkvist H et al (2017) Cognitive function in stroke survivors: a 10-year follow-up study. Acta Neurol Scand 136(3):187–194. https://doi.org/10.1111/ane.12709
Heye AK, Thrippleton MJ, Armitage PA et al (2016) Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. NeuroImage 125:446–455. https://doi.org/10.1016/j.neuroimage.2015.10.018
Sood RR, Taheri S, Candelario-Jalil E et al (2008) Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 28(2):431–438. https://doi.org/10.1038/sj.jcbfm.9600534
Portegies ML, Wolters FJ, Hofman A et al (2016) Prestroke vascular pathology and the risk of recurrent stroke and poststroke dementia. Stroke 47(8):2119–2122. https://doi.org/10.1161/STROKEAHA.116.014094
Mok VC, Lam BY, Wong A et al (2017) Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms. Nat Rev Neurol 13(3):148–159. https://doi.org/10.1038/nrneurol.2017.16
Tobinick E (2011) Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs 25(2):145–155. https://doi.org/10.2165/11588400-000000000-00000
Krafft PR, Bailey EL, Lekic T et al (2012) Etiology of stroke and choice of models. Int J Stroke 7(5):398–406. https://doi.org/10.1111/j.1747-4949.2012.00838.x
Gennaro M, Mattiello A, Pizzorusso T (2019) Rodent models of developmental ischemic stroke for translational research: strengths and weaknesses. Neural Plast 2019:5089321. https://doi.org/10.1155/2019/5089321
Stamatovic SM, Phillips CM, Keep RF et al (2020) A novel approach to treatment of thromboembolic stroke in mice: redirecting neutrophils toward a peripherally implanted CXCL1-soaked sponge. Exp Neurol 330:113336. https://doi.org/10.1016/j.expneurol.2020.113336
Sladojevic N, Stamatovic SM, Johnson AM et al (2019) Claudin-1-dependent destabilization of the blood-brain barrier in chronic stroke. J Neurosci 39(4):743–757. https://doi.org/10.1523/JNEUROSCI.1432-18.2018
Garbuzova-Davis S, Haller E, Williams SN et al (2014) Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage. J Comp Neurol 522(13):3120–3137. https://doi.org/10.1002/cne.23582
Morimoto T, Yasuhara T, Kameda M et al (2011) Striatal stimulation nurtures endogenous neurogenesis and angiogenesis in chronic-phase ischemic stroke rats. Cell Transplant 20(7):1049–1064. https://doi.org/10.3727/096368910X544915
Spychala MS, Venna VR, Jandzinski M et al (2018) Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome. Ann Neurol 84(1):23–36. https://doi.org/10.1002/ana.25250
Kim H, Seo JS, Lee SY et al (2020) AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice. Brain Behav Immun 87:765–776. https://doi.org/10.1016/j.bbi.2020.03.011
Choi C, Kim HM, Shon J et al (2018) The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model. Cytotherapy 20(6):820–829. https://doi.org/10.1016/j.jcyt.2018.04.004
Tajiri N, Lee JY, Acosta S et al (2016) Breaking the blood-brain barrier with mannitol to aid stem cell therapeutics in the chronic stroke brain. Cell Transplant 25(8):1453–1460. https://doi.org/10.3727/096368916X690971
Bihel E, Pro-Sistiaga P, Letourneur A et al (2010) Permanent or transient chronic ischemic stroke in the non-human primate: behavioral, neuroimaging, histological, and immunohistochemical investigations. J Cereb Blood Flow Metab 30(2):273–285. https://doi.org/10.1038/jcbfm.2009.209
Stamatovic SM, Johnson AM, Keep RF et al (2016) Junctional proteins of the blood-brain barrier: new insights into function and dysfunction. Tissue Barriers 4(1):e1154641. https://doi.org/10.1080/21688370.2016.1154641
Sweeney MD, Zhao Z, Montagne A et al (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99(1):21–78. https://doi.org/10.1152/physrev.00050.2017
Mintzopoulos D, Khanicheh A, Konstas AA et al (2008) Functional MRI of rehabilitation in chronic stroke patients using novel MR-compatible hand robots. Open Neuroimaging J 2:94–101. https://doi.org/10.2174/1874440000802010094
Taheri S, Gasparovic C, Huisa BN et al (2011) Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 42(8):2158–2163. https://doi.org/10.1161/STROKEAHA.110.611731
Sladojevic N, Stamatovic SM, Keep RF et al (2014) Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury. Neurobiol Dis 67:57–70. https://doi.org/10.1016/j.nbd.2014.03.010
Stamatovic SM, Shakui P, Keep RF et al (2005) Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25(5):593–606. https://doi.org/10.1038/sj.jcbfm.9600055
Beller E, Reuter L, Kluge A et al (2018) Pilot study to assess visualization and therapy of inflammatory mechanisms after vessel reopening in a mouse stroke model. Sci Rep 8(1):745. https://doi.org/10.1038/s41598-017-17533-5
Johnson AM, Roach JP, Hu A et al (2018) Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure. FASEB J 32(5):2615–2629. https://doi.org/10.1096/fj.201700699R
Overgaard K, Sereghy T, Boysen G et al (1992) A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab 12(3):484–490. https://doi.org/10.1038/jcbfm.1992.66
He Z, Wang X, Wu Y et al (2014) Treadmill pre-training ameliorates brain edema in ischemic stroke via down-regulation of aquaporin-4: an MRI study in rats. PLoS One 9(1):e84602. https://doi.org/10.1371/journal.pone.0084602
Ohno K, Chiueh CC, Burns EM et al (1980) Cerebrovascular integrity in protein-deprived rats. Brain Res Bull 5(3):251–255. https://doi.org/10.1016/0361-9230(80)90166-5
Acknowledgments
This work is supported by NIH grants: AG057928 to A.V.A. and NS098211 to S.M.S.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Stamatovic, S.M., Phillips, C.M., Keep, R.F., Andjelkovic, A.V. (2022). An In Vivo Mouse Model to Study Blood–Brain Barrier Destabilization in the Chronic Phase of Stroke. In: Stone, N. (eds) The Blood-Brain Barrier. Methods in Molecular Biology, vol 2492. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2289-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2289-6_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2288-9
Online ISBN: 978-1-0716-2289-6
eBook Packages: Springer Protocols